Ledger.Open graph →
SEC Form D · filed December 30, 2020

CiVi Biopharma Holdings, Inc

Offering
$27.5M
Sold
$27.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Chevy Chase, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Carole Nuechterlein · Bryn Mawr, PADirectorChristopher Fuglesang · Bryn Mawr, PADirectorShalom Jacobovitz · Bryn Mawr, PAExec · DirectorMatthew Pietras · Chevy Chase, MDExecAaron Davis · Bryn Mawr, PADirectorHenrik Oerum · Bryn Mawr, PADirectorChristopher Fuglesang · Bryn Mawr, PADirectorMatthew Pietras · Chevy Chase, MDExecCarole Nuechterlein · Bryn Mawr, PADirectorShalom Jacobovitz · Bryn Mawr, PAExec · DirectorAaron Davis · Bryn Mawr, PADirectorHenrik Oerum · Bryn Mawr, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗